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Abstract
Clinical spinal cord injury (SCI) is accompanied by comorbid peripheral injury in 47% of patients. Human and animal
modeling data have shown that painful peripheral injuries undermine long-term recovery of locomotion through
unknown mechanisms. Peripheral nociceptive stimuli induce maladaptive synaptic plasticity in dorsal horn sensory
systems through AMPA receptor (AMPAR) phosphorylation and trafficking to synapses. Here we test whether ventral
horn motor neurons in rats demonstrate similar experience-dependent maladaptive plasticity below a complete SCI in
vivo. Quantitative biochemistry demonstrated that intermittent nociceptive stimulation (INS) rapidly and selectively
increases AMPAR subunit GluA1 serine 831 phosphorylation and localization to synapses in the injured spinal cord,
while reducing synaptic GluA2. These changes predict motor dysfunction in the absence of cell death signaling,
suggesting an opportunity for therapeutic reversal. Automated confocal time-course analysis of lumbar ventral horn
motor neurons confirmed a time-dependent increase in synaptic GluA1 with concurrent decrease in synaptic GluA2.
Optical fractionation of neuronal plasma membranes revealed GluA2 removal from extrasynaptic sites on motor
neurons early after INS followed by removal from synapses 2 h later. As GluA2-lacking AMPARs are canonical
calcium-permeable AMPARs (CP-AMPARs), their stimulus- and time-dependent insertion provides a therapeutic
target for limiting calcium-dependent dynamicmaladaptive plasticity after SCI. Confirming this, a selective CP-AMPAR
antagonist protected against INS-induced maladaptive spinal plasticity, restoring adaptive motor responses on a
sensorimotor spinal training task. These findings highlight the critical involvement of AMPARs in experience-dependent
spinal cord plasticity after injury and provide a pharmacologically targetable synaptic mechanism by which early
postinjury experience shapes motor plasticity.
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Significance Statement
Recent findings have demonstrated that painful stimuli below a spinal cord injury can affect future
locomotor training and recovery in spinal cord injured patients (Bouffard et al., 2014), as well as in animal
models (Ferguson et al., 2008a; Ferguson et al., 2012a; Ferguson et al., 2012b). However, the cellular and
molecular mechanisms for this experience-dependent modulation of spinal cord plasticity are poorly
understood. This work uncovers a novel synaptic mechanism by which peripheral nociceptive (painful) input
following a spinal cord injury can undermine future adaptive spinal cord plasticity, providing a novel target
for improving recovery after spinal cord injury, and mitigating aberrant forms of spinal neuroplasticity.
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Introduction
In the human spinal cord injury (SCI) population there is
a high incidence of concomitant peripheral injury, includ-
ing lacerations, abrasions, and fractured limbs (Saboe
et al., 1991; Sekhon and Fehlings, 2001; Wang et al.,
2001; Hasler et al., 2011). Although these injuries may be
considered minor in comparison to the SCI, the nocicep-
tive input to the spinal cord produced by these peripheral
injuries may have a lasting effect on recovery of sensory
and motor function. A large body of preclinical work has
demonstrated that peripheral nociceptive input produces
lasting alterations in dorsal horn neurons through cellular
mechanisms similar to those underlying hippocampal
learning and memory (Sandkühler and Liu, 1998; Ikeda,
2006). These spinal cord “pain memory” signatures have
been suggested to underlie pain disorders, such as hy-
peralgesia and neuropathic pain (Ji et al., 2003; Sandküh-
ler, 2009; Ruscheweyh et al., 2011; Drdla-Schutting et al.,
2012).
Peripheral nociceptive input affects not only dorsal pain
pathways, but also spinal motor systems. Peripheral in-
termittent nociceptive stimulation (INS) below a SCI pro-
duces nociceptive hyper-reflexia, acute deficits in
adaptive spinal motor learning, and lasting (6 weeks)
impairment in recovery of locomotor function (Grau et al.,
1998, 2004,2012; Garraway et al., 2011, 2014; Huie et al.,
2012b). Such findings suggest that the injured spinal cord
is highly vulnerable to peripheral sensory input, with a
heightened capacity for the spinal motor systems to en-
code maladaptive forms of synaptic plasticity. The clinical
relevance of peripherally-induced spinal cord maladaptive
plasticity was highlighted by a recent clinical study dem-
onstrating that brief peripheral nociceptive input under-
mines the ability of human SCI patients to retain
locomotor learning tasks (Bouffard et al., 2014).
Although a growing body of work has sought to deter-
mine the neural mechanisms underlying maladaptive
plasticity in pain pathways, it is unknown whether
nociception-induced alterations in motor circuits reflect
these same processes. One key aspect of spinal cord
pain plasticity is the postsynaptic alteration of fast-
excitatory glutamate AMPA receptors (AMPARs; Hart-
mann et al., 2004; Galan et al., 2004). Recent work has
also highlighted the specific role of AMPAR subunit phos-
phorylation site serine 831 in encoding activity-dependent
spinal cord pain memory traces in dorsal spinal neurons
following peripheral stimulation (Drdla-Schutting et al.,
2012).
It has been recently shown that SCI specifically in-
creases postsynaptic localization of GluA2-lacking,
calcium-permeable AMPA receptors (CP-AMPARs) on
motor neurons (Ferguson et al., 2008b). In addition,
AMPAR activity impacts spinal cord motor training, sug-
gesting potential for dynamic modulation of AMPARs in
spinal cord motor systems (Hoy et al., 2013). The synaptic
insertion and activation of CP-AMPARs are crucial to the
induction of synaptic plasticity and homeostatic scaling in
CNS neurons in vitro (Man, 2011; Garcia-Bereguiain et al.,
2013). CP-AMPARs are normally highly regulated, and are
trafficked out of synaptic sites; however, under patho-
physiologic conditions, CP-AMPAR activity may be dys-
regulated and sustained, overdriving excitation and
ultimately inducing cell death (Kuner et al., 2005; von
Lewinski and Keller, 2005; Liu et al., 2006; Ferguson et al.,
2008b; Oh et al., 2012; Spaethling et al., 2012; Dias et al.,
2013).
Given these prior findings, we hypothesized that noci-
ceptive input induces maladaptive spinal cord plasticity
by overdriving CP-AMPARs in motor neurons in the in-
jured spinal cord. We applied a well established peripheral
nociceptive stimulation procedure to induce maladaptive
motor plasticity, and tested for AMPAR and downstream
signaling changes by quantitative biochemistry, robotic
confocal image analysis, and behavioral assessments at
acute time-points following complete SCI. The results
uncovered a time dependent overdrive of CP-AMPARs
that was independent of cell death and pharmacologically
targetable to reset spinal cord plasticity below SCI.
Materials and Methods
Animals
Male Sprague-Dawley rats (Harlan), aged 100–120 d were
housed individually and had ad libitum access to food and
water (N  64). All procedures were conducted in accor-
dance with the National Institute of Health Guide for the
Care and Use of Laboratory Animals, and all efforts were
made to minimize suffering and limit the number of ani-
mals used. All protocols were approved by the University
Laboratory Animal Care Committee at Texas A&M Univer-
sity.
Experimental methodology
In all experiments, experimenters were kept blind to treat-
ment conditions throughout the entire study in accor-
dance with recent quality standards for preclinical
neurological research (Landis et al., 2012). Western blot
loading order was determined a priori by a third-party
coder who insured that a representative sample from
each condition was included on each gel in a randomized
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block design. For each experiment, the number of sub-
jects per condition was kept consistent across groups to
insure proper counterbalancing could be achieved across
independent Western runs. All representative Western im-
ages presented in the figures represent lanes from the
same gel. Because of our randomized counterbalancing
scheme, occasionally the critical comparisons of interest
were not available on adjacent lanes (but do come from
the same gel). The entire set of randomized Western blot
images are available upon request. Confocal image ac-
quisition and subsequent data analyses were also per-
formed by experimenters blind to treatment condition.
Spinal transection surgery
All animal subjects received a complete transection of the
spinal cord immediately rostral to the second thoracic
vertebra (T2). Animals were fully anesthetized with isoflu-
rane gas (5%). Fur over the thoracic vertebra was shaved,
and a 3 cm incision was made over T2. The tissue imme-
diately rostral to T2 was cleared away with rongeurs, and
the underlying spinal cord was exposed. An electrical heat
cautery device was used to transect the spinal cord and
the resulting cavity was filled with gelfoam (Harvard Ap-
paratus). The incision was then closed using Michel clips
(Fine Science Tools). Animals received a 2.5 ml intraperi-
toneal injection of 0.9% saline immediately following sur-
gery, and twice daily for subsequent days to ensure
proper hydration. Bladders were expressed twice daily.
Given the nociceptive nature of this study, no analgesics
were given following complete spinal transection.
Intermittent nociceptive stimulation
Twenty-four hours after complete spinal transection sur-
gery, animals were placed in black Plexiglas tubes, 22 cm
in length and 6.8 cm in diameter. The tail was allowed to
hang freely from the end of the tube, and an electrode
coated in ECG gel was fixed to the tail 6 cm from the
base of the tail using orthaletic tape. Constant-current 1.5
mA, AC stimulation was delivered to the electrode using a
660 V transformer. Stimulation delivery was controlled by
computer program, with each pulse 80 ms in duration
delivered intermittently over 6 min, on a variable inter-
stimulus interval (range 0.2–3.8 s; mean 2 s). This sched-
ule resulted in a total of 180 stimulation presentations.
Each animal received either a single 6 min stimulation
session, or an equivalent period of unstimulated restraint
with the electrodes attached.
Western blot
Animals were deeply anesthetized with pentobarbital (100
mg/kg, i.p.), decapitated, and spinal cords were har-
vested by rapid fluid expulsion with ice-cold phosphate-
buffered saline (PBS) at 20 min, 2 h, or 24 h following
nociceptive stimulation. Spinal cords were immediately
flash-frozen in liquid nitrogen, and then transferred to
80°C. The entire surgical procedure was timed to ensure
time from decapitation to snap freeze was 5 min.
Fresh-frozen spinal cords were subsequently rapidly
thawed on a chilled petri dish at 4°C, and a 1 cm section
of the lumbar enlargement was dissected. This section
was then split once along the midline, followed by a cut to
separate the dorsal and ventral quadrants (Fig. 1A). A
single quadrant containing the ventral horn was then
placed in a Dounce homogenizer filled with 200 m ho-
mogenization buffer (10 mM Tris, 30 mM sucrose, pH 7.5)
containing phosphatase and protease inhibitors (Roche).
Following tissue disruption, the whole homogenate was
placed in an Eppendorf tube, and spun at 5000 relative
centrifugal force (rcf) for 5 min in a minicentrifuge at 4°C.
This centrifugation procedure produced a supernatant
(S1) and a nuclear pellet (P1). The S1 layer was removed
and centrifuged a second time at 13,000 rcf for 30 min at
4°C, producing a modestly synaptoneurosomal-enriched
pellet fraction (P2) that was subsequently used in Western
blots (Fig. 1B; Galan et al., 2004; Ferguson et al., 2008b;
Stück et al., 2012). Total protein concentration was quan-
tified using the Pierce BCA protein assay method. Each
sample was then diluted 1:2 in room temperature Laemmli
sample buffer, and 20 g of total protein per sample was
loaded into separate lanes on a precast 10–20% electro-
phoresis gel (Tris-HCl polyacrylamide, BioRad). Samples
were counterbalanced across the gel by treatment con-
dition, and the experimenter was kept blind to condition.
A kaleidoscope ladder was loaded on each gel to confirm
molecular weight. The gel was electrophoresed for 1 h at
100 V in SDS buffer (25 mM Tris, 192 mM glycine, 0.1%
SDS, pH 8.3; BioRad). Protein was transferred to a nitro-
cellulose membrane in cold transfer buffer (25 mM Tris,
192 mM glycine, 20% methanol, pH 8.3). The membrane
was blocked for 1 h in Odyssey Blocking Buffer (LiCor)
containing 0.1% Tween 20, followed by an overnight
incubation in primary antibody solution at 4°C. Primary
antibody solution consisted of rabbit polyclonal anti-
phosphorylated serine 831 (1:200; Millipore), in Odyssey
blocking buffer plus 0.05% Tween 20. Following incuba-
tion, the membrane was washed 4  5 min with Tris-
buffered saline containing 0.1% Tween 20 (TTBS) and
incubated in fluorescent-labeled secondary antibody (1:
30K LiCor IRdye 680 goat anti-rabbit in Odyssey blocking
buffer plus 0.2% Tween 20) for 1 h in the dark. Subse-
quent to 4  5 min washes in TTBS, followed by a 5 min
wash in TBS. The membrane was immediately scanned
on the LiCor Odyssey Infrared Imaging System with a 680
nm laser to reveal protein bands. The membrane was then
re-blocked and reincubated with mouse anti-GluA1 pri-
mary antibody (1:200, Millipore) in Odyssey blocking buf-
fer plus 0.05% Tween 20. The membrane was then
washed as before, and incubated in fluorescent-labeled
secondary antibody (1:30K LiCor IRdye 800 goat anti-
mouse in Odyssey blocking buffer plus 0.2% Tween 20),
washed as before, and rescanned with the 800 nm laser
to reveal GluA1 protein bands. This same protocol was
performed for serine 845 on GluA1, GluA2, and Serine 880
on GluA2. Loading controls were performed as the last
step on each multiplexed Western blot. Cell death marker
assays (cFos, cJun, calpain I, and cleaved caspase,
1:250; Cell Signaling Technologies), were performed on a
separate set of gels that were performed on cytosolic (S2)
fractions. Otherwise, the Western blot protocols for cell
death markers were identical to those used for AMPAR
assays.
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To ensure accurate protein quantification, we used pro-
tein dilution curves for each primary antibody to detect
the linear range in which fluorescence was most highly
correlated with changes in protein concentration using
Odyssey Application Software v3.0. The optimal dilution
and laser intensity at which protein concentration and
fluorescence yielded the greatest linear correlation was
established separately for each antibody and then held
constant for the duration of the experiment (all R2 0.98).
Fluorescence for each band was quantified using Odys-
sey software and normalized to median pixel density of
background fluorescence.
Immunohistochemistry
Animals (n  4 per group) underwent intracardial perfu-
sion under deep (100 mg/kg) pentobarbital anesthesia,
Figure 1. Subcellular fractionation of ventral lumbar spinal cord. A, Ventral quadrant of lumbar spinal cord tissue was dissected and
homogenized using a Dounce homogenizer. The whole homogenate was then centrifuged for 5 min at 5000 rcf, and the supernatant
(S1) was removed. This S1 fraction was then centrifuged for 30 min at 13,000 rcf. The pellet from this fraction (P2) was then used for
all subsequent Western blots. B, Plasma membrane enrichment in the P2 fraction was confirmed with N-cadherin expression, and
modest synaptic enrichment (synaptoneurosome) was characterized by PSD-95, with beta-actin serving as loading control. C,
Tissue-oriented coordinate grid placement for systematic cell selection. Large ventral horn neurons were systematically selected from
spinal cord slices in L4–L5 region. A microscopist blind to experimental condition entered the stage coordinate location of four
anatomical landmarks (central canal, anterior artery, left edge of tissue, right edge of tissue) into an Excel spreadsheet, and a custom
VisualBasic macro generated a list of microscope stage coordinates that were then input into MicroManager and ImageJ software that
controlled microscope stage movement. This system ensured that the orientation of the coordinate grid would always be relative to
the specific orientation of the tissue. Each coordinate signified the center of an 80  80m sampling window, with each coordinate
spaced 100 m apart. The blind microscopist cycled through these sampling windows at 63. When a large neuron (cell body 40
m) was encountered within a sampling window, the cell was centered in the frame and a stack of images was taken through the
z-plane, with separate images taken through a 650 nm filter (for synaptophysin) and a 490 nm filter (for GluA1 or GluA2) at each level.
D, Optical detection of synaptic AMPAR subunits. Yellow pixels produced by the overlapping of the presynaptic marker synapto-
physin (red) and postsynaptic AMPAR subunit (green) puncta indicated colocalization and were quantified to determine the amount
of synaptic AMPAR subunit expression. E, All image stacks were combined and deconvolved to correct for the diffusion of light using
AutoQuant software.
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either 20 min or 2 h post-INS. Animals were perfused first
with ice cold PBS, followed by 4% paraformaldehyde to
fix tissue. The spinal cord was excised and postfixed
overnight (18 h) in 4% paraformaldehyde then cryopro-
tected in 30% sucrose for 2 d. The tissue was embedded
in OCT within 10 mm blocks, flash frozen on dry ice, and
sectioned into 20-m-thick coronal slices.
The L4–L5 region of the spinal cord was identified
anatomically using Luxol Fast Blue (LFB) staining. The
tissue was dried for 1 h and hydrated with 1:1 95%
ethanol to chloroform for 4 h. Slides were incubated in a
solution of 0.1% LFB for 18 h at 56°C. The tissue was then
washed in water and the LFB stain was differentiated by a
20 s 0.1% lithium carbonate wash. The tissue was
washed again with water. Tissue was soaked in 95%
ethanol for 2 min, 100% ethanol for 5 min, and another
bath of 100% ethanol for 5 min. Slides were coverslipped
with DPX mounting medium.
Four fixed-tissue sections from the L4–L5 region of the
spinal cord from each subject were antibody-labeled us-
ing a high-throughput staining station (Sequenza; Thermo
Scientific). Tissue was blocked and permeabilized with
5% normal goat serum and 0.3% Triton X-100 for 1 h and
incubated overnight at room temperature in primary anti-
body solution consisting of mouse monoclonal anti-
presynaptic synaptophysin (1:200; Millipore) and either
rabbit monoclonal antibody against GluA1 (1:200; Up-
state) or rabbit polyclonal antibody against GluA2 (1:200;
Chemicon). Slides were washed 2  5 min with 2 ml PBS
then incubated for 1 h at room temperature in a secondary
solution containing 1:100 AlexaFluor 488 goat anti-rabbit
and 1:100 AlexaFluor 633 goat anti-mouse secondary
antibodies. Slides were washed 2  5 min with 2 ml PBS,
and then coverslipped with Vectashield containing DAPI
(4=, 6-diamidino-2-phenylindole; Vector Laboratories).
AMPAR GluA1 and GluA2 subunits were assessed on
adjacent slide sets from the same subjects.
Robotic confocal microscopy sampling and
deconvolution
A Nikon spinning disk confocal microscope (63 objec-
tive; NA  1.4; 2 zoom) was used to collect confocal
images of large ventral neurons. To systematically sample
motor neurons, a custom Visual Basic program was used
to automatically overlay a sampling grid on the ventral half
of each spinal section, aligned to the central canal and
ventral artery as fiduciary points. This grid contained 90
90 m sampling windows that were spaced 100 m apart
both horizontally and vertically (Fig. 1C). Large neurons
were identified based on the distinctive synaptophysin
outline surrounding the plasma membrane and character-
ized by a cell body diameter 40 m (Fig. 1C). A micros-
copist blind to condition used ImageJ software (v1.47,
NIH) on the confocal microscope to advance through
each sampling window, and gathered confocal images of
neurons if they were encountered in the sampling window.
If a sampling window contained multiple neurons, a single
neuron was chosen at random. Control tissue was used to
optimize filter and laser settings, which were then held
constant throughout the experiment. Confocal z-stacks
consisted of slices collected at 0.25 m z-intervals. Con-
focal stacks were batch deblurred off-line using 3-D blind
iterative deconvolution (AutoQuant; Fig. 1E). Based on a
random subset of images an experimentally blind rater
determined the number of iterations for the deconvolution
algorithm to yield maximal resolution for each antibody
(iteration  4 for GluA1; iteration  2 for GluA2). Once
selected a priori, iteration numbers were held constant
throughout the experiment. A total of 539 cells were
assessed for GluA1, and 484 cells were assessed for
GluA2. A total of 23,723 optical planes were analyzed,
with an average number of 23 optical planes per cell.
We used automated image analysis to quantify the
number of fluorescently labeled AMPAR puncta that ex-
ceeded a predetermined pixel threshold that was based
on control tissue. Automated image analysis was per-
formed using custom-designed MetaMorph (Molecular
Devices) macros. One macro quantified AMPAR puncta at
the level of the neuropil. This macro measured the amount
of total AMPAR pixels as well as colocalized synaptophy-
sin and AMPAR pixels in each plane of the z-stack. An-
other macro quantified fluorescently labeled AMPAR
puncta on the plasma membrane of motor neurons. This
macro first identified the plane in the z-series with the
highest amount of synaptophysin and AMPAR subunit
(GluA1 or GluA2) synaptic colocalization. The automated
plane selection was monitored by a blinded researcher to
prevent selection based on staining artifacts. A blinded
researcher traced the synaptophysin labeled plasma
membrane of the motor neuron on a single optical
plane. The macro then generated a 2-m-thick cutout
containing the plasma membrane “optical fraction” of
the cell from the single plane. From the plasma mem-
brane containing cutout, MetaMorph quantified total
AMPAR subunit pixels and colocalized AMPAR pixels
with synaptophysin pixels (Fig. 1D).
Intrathecal drug delivery
To inhibit CP-AMPAR activity, the specific antagonist
Naspm (Sigma-Aldrich) was delivered intrathecally. A subset
of animals (n  12 per group) were fitted with an intrathecal
cannula at the time of spinal transection. The 25 cm cannula
was threaded into the subarachnoid space at the second
thoracic vertebra, and slid 9 cm caudally so that the tip of the
cannula rested on the dorsal surface of the L4–L5 section of
the spinal cord. Immediately following nociceptive stimula-
tion, a 10 l Hamilton syringe was fitted onto the exposed
end of the cannula, and 10 l of either Naspm (10 mM) or
saline vehicle was delivered over the 3 min. This injection
was followed by a 20 l flush with saline, and the exposed
end of the cannula was then heat-sealed.
Spinal sensorimotor task
Testing of spinal learning was conducted 24 h after com-
plete spinal transection. Animals were loosely restrained
in black Plexiglas tubes (22 cm in length  6.8 cm in
diameter). To limit the effects of trunk movement on
hindlimb position while in the tube, a wire belt was
wrapped around the animal’s trunk. Hindlimbs were al-
lowed to hang freely from the tube. One hindlimb was
shaved, and a wire electrode was inserted through the
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skin over the ankle, distal to the tibialis anterior muscle. A
second electrode was inserted into the body of the tibialis
anterior muscle, 1.7 cm from the first electrode. This
second electrode was connected to a wire running to a
BRS/LVE constant current shock generator (60 Hz, AC). A
stainless steel contact electrode (7 cm in length, 0.46 cm
in diameter) was secured to the hindpaw between the sec-
ond and third digits with a piece of porous orthaletic tape. A
wire extending from the contact electrode was connected to
a computer-monitored digital input. Prior to testing, intensity
of the stimulation was adjusted for each animal so that a 0.4
N force in flexion was elicited. Force was recorded by at-
taching a monofilament plastic line around the animal’s
hindpaw, and running this line to a strain gauge (Fort-1000,
World Precision Instruments). This strain gauge was con-
nected to a multimeter calibrated to convert a change in
voltage to force in Newtons. Brief (300 ms) shock pulses
were then delivered to the anterior tibialis muscle, and the
force of ankle flexion was recorded. Intensity was then ad-
justed until a 0.4 N force in flexion was achieved. After the
intensity of stimulation was determined to elicit a 0.4 N
flexion, the monofilament line was removed.
A rectangular plastic dish containing a salt solution was
positioned 7.5 cm below the restraining tube. The level of
salt solution was adjusted so that the contact electrode
that extended from the rat’s hindpaw was submerged 4
mm in the solution. A stainless steel rod (1 mm in diam-
eter) connected to a ground wire was then placed in the
salt solution and the computer-controlled 30 min testing
session was started. Whenever the contact electrode was
submerged in the salt solution, a circuit was completed,
the state of which was relayed to the stimulator, and
stimulation was delivered to the tibialis anterior. Whenever
the contact electrode was raised from the salt solution,
the stimulation was terminated.
Three behavioral measures were taken during the test-
ing session: time in solution, response number, and re-
sponse duration. The computer monitoring the state of
the circuit recorded the total amount of time that the
contact electrode was in the salt solution for each 1 min
time bin. Each time the contact electrode was lifted from
the salt solution, response number was increased. Re-
sponse duration was calculated from time in solution and
response number according to the equation: Response
Durationi  (60 s  Time in Solutioni)/(Response Number
 1), where i is the current 1 min time bin.
Statistical analyses
Statistical analyses were performed using SPSS Statistics
(v.20, IBM). Parametric Western blot data for each experi-
ment were pooled across three independent replications
and covariance corrected by beta-actin loading control, with
replication statistically controlled as a random factor. A
mixed-model analysis of covariance (ANCOVA; with beta-
actin loading control as covariate) was used to test for main
effects and interactions between time and stimulation con-
dition. Tests of main effects were followed by planned pair-
wise comparisons of control/experimental group estimated
marginal means at each timepoint (least significant differ-
ence). Confocal and behavioral data were assessed by
ANOVA, followed by Tukey’s post hoc tests of groupmeans.
Ratio data were analyzed with Student’s t test, followed by
Mann–Whitney U to rule out nonparametric effects. Signifi-
cance was assessed at p 0.05. Power and effect sizes for
analyses can be found in Table 1, and referred to by super-
script letters throughout the results section.
Results
INS drives GluA1 but not GluA2 subunits into
synaptoneurosomes in a time-dependent fashion
To assess the role of AMPAR activity in maladaptive
spinal plasticity we applied an INS procedure (Fig. 2A)
that induces maladaptive behavioral effects, including no-
ciceptive hyper-reactivity, impaired spinal cord motor
Table 1: Statistical Analyses
Results Type of Test
Effect Size
(Eta Squared) Observed Power
a GluA1 Western blot, Time  Stimulation interaction ANCOVA 0.231 0.940
b GluA2 Western blot, Time  Stimulation interaction ANCOVA 0.025 0.178
c GluA1: GluA2 ratio t test 0.592 0.694
d p-S831 Western blot, Time  Stimulation interaction ANCOVA 0.273 0.975
e p-S880 Western blot, Time  Stimulation interaction ANCOVA 0.067 0.406
f Western blot cell death markers ANCOVA 0.023 0.170
g GluA1 neuropil expression, main effects of time
and stimulation
ANOVA Effect of time: 0.066
Effect of stimulation: 0.053
Effect of time: 1.000
Effect of stimulation: 1.000
h GluA2 neuropil expression, Time  Stimulation
interaction
ANOVA 0.036 0.991
i GluA1 extrasynaptic membrane expression, Time 
Stimulation interaction
ANOVA 0.016 0.847
j GluA1 synaptic expression, main effects of time
and stimulation
ANOVA Effect of time: 0.111
Effect of stimulation: 0.015
Effect of time: 1.000
Effect of stimulation: 0.800
k GluA2 extrasynaptic membrane expression, main
effects of time and stimulation
ANOVA Effect of time: 0.030
Effect of stimulation: 0.125
Effect of time: 0.973
Effect of stimulation: 1.000
l GluA2 synaptic expression, Time  Stimulation
interaction
ANOVA 0.035 0.988
m Response duration, sensorimotor learning task,
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training, and impaired recovery of function after SCI
(Crown et al., 2002b; Grau et al., 2004; Ferguson et al.,
2006), and measured AMPAR changes within lumbar spi-
nal cord synaptoneuromes by quantitative near-IR West-
ern blotting (Fig. 2B). Time-series data indicated that INS
increases GluA1 subunit localization to synaptic fraction
by 20 min with no change in GluA2 (Fig. 2C). ANCOVA
(with beta-actin as covariate) revealed a significant Time
 Stimulation interaction for GluA1 (F(1,43)  13.10
a, p 
0.05), but not GluA2 (F(1,43) 1.12
b, p 0.05). A Student’s
t test revealed a significant increase in the GluA1/GluA2
ratio at 20 min post-INS (Fig. 2D; p  0.05c). A Mann–
Whitney U test was also used to rule out any nonpara-
metric effects, and this test confirmed the t test result.
These effects resolved by 2 h poststimulation (Fig. 2E,F).
Pairwise comparisons at each time point revealed a
significant increase in GluA1 in stimulated animals at 20
min (Fig. 2C; p  0.05), but not at 2 h (Fig. 2E; p  0.05).
Figure 2. Plasma membrane GluA1 and GluA2 phosphorylation with intermittent nociceptive stimulation delivered below complete
spinal cord injury. A, Intermittent nociceptive stimulation. Rats with complete spinal transections received 6 min of intermittent
nociceptive stimulation to the tail. Unstimulated controls received an equivalent period of restraint. B, Quantitative fluorescent
intensity optimized for linear detection of each target band using a 1:2 dilution curve of total protein. Laser scanning intensity for each
target protein was chosen based on closest linear relationship between fluorescent intensity and total protein (all R2  0.98). All
subsequent analyses for each target protein were run at their respective optimal scanning intensities to ensure linearity of
fluorescence (see Materials and Methods for details). C, Linear quantification of GluA1 and GluA2 AMPAR subunits, 20 min
poststimulation. Stimulation significantly increased GluA1 expression compared to unstimulated controls (p  0.05), whereas GluA2
expression was unchanged. D, The ratio of GluA1 to GluA2 subunit expression was significantly increased in stimulated animals within
20 min (Mann–Whitney U; p 0.05). E, F, Linear quantification of GluA1 and GluA2 AMPAR subunits, 2 h poststimulation. Stimulation
had no significant effect on GluA1 or GluA2 after 2 h (p  0.05). G, Linear intensity optimization on phosphorylated serines 831 and
880. H, Linear quantification of p-S831 and p-S880 protein expression 20 min poststimulation. Stimulation significantly increased
phosphorylated serine 831 expression relative to unstimulated controls (p  0.05), whereas phosphorylated serine 880 was
unchanged. I, Stimulation had no significant effect on p-S831 or pS880 after 2 h (p  0.05). All bars represent mean for n  4
subjects/per group (n  8 for main effects, n 4 for interaction) with three independent Western blot runs per subject. Error bars
represent standard error of the mean.
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In contrast, there was no significant pairwise effect of
stimulation on GluA2 at either time point (Fig. 2C,E; p 
0.05). Together the results suggest that INS drives
GluA2-lacking AMPARs into synapses in the ventral
spinal cord in a time-dependent fashion.
Serine 831 phosphorylation of synaptic GluA1 in the
injured spinal cord
Given that GluA2-lacking AMPARs are calcium permeable
(Hollmann et al., 1991), the current study provide a po-
tential mechanism for prior findings that INS engages
calcium-dependent kinases, protein kinase C (PKC), and
calcium-calmodulin-dependent kinase II (CaMKII; Baum-
bauer et al., 2007; Ferguson et al., 2008a; Huie et al.,
2012a). PKC and CamKII modulate ongoing AMPAR ac-
tivity by phosphorylating serine 831 (p-S831) on GluA1
and serine 880 (p-880) GluA2 (Roche et al., 1996; Mat-
suda et al., 1999). Quantitative phospho-Western blot of
these targets revealed that INS transiently increased
p-S831 on GluA1 by 20 min resolving by 2 h (Fig. 2H,I). No
change was observed in p-S880 on GluA2 (Fig. 3H,I).
ANCOVA (beta-actin covariate) confirmed Time  Stimu-
lation interaction for GluA1 p-S831 (F(1,43)  16.10
d, p 
0.05), but no effect for GluA2 p-S880 (F(1,43)  3.10
e, p 
0.05). Pairwise comparisons at each time point confirmed
a significant increase in p-S831 at 20 min (Fig. 3H; p 
0.05) but not 2 h (Fig. 3I; p 0.05). As with GluA2, p-S880
expression was not affected by stimulation at either time
point (p  0.05). We also found no significant effect of
time or stimulation on phosphorylated serine 845, the PKA
binding site for GluA1 (p  0.05, data not shown). The
phospho-assay results confirm a selective and time-
dependent increase in GluA1 p-S831, a known gain-of-
function modification of GluA1 conferred by PKC and
CaMKII (Roche et al., 1996; Lee et al., 2000). Together
with the subcellular localization data, the results suggests
that nociceptive stimulation increases neural excitability in
two ways: (1) by increasing GluA2-lacking localization to
synaptic sites, and (2) by increasing the function of these
inserted AMPARs through PKC/CamKII-phosphorylation
(Ferguson et al., 2006; Hook et al. 2008).
Nociceptive stimulation below SCI does not induce
acute cell death in lumbar ventral horns
GluA2-lacking AMPARs have previously been shown to
contribute to cell death of large motor neurons in the SCI
lesion penumbra, leading us to ask whether INS modu-
lates cell death in an experience-dependent fashion. We
ran a panel of biomarkers for proteins associated with
increased cellular activity, excitotoxicity, and/or apoptotic
cell death (Fig. 3). Cytosolic subcellular fractions of ventral
lumbar spinal homogenates were assessed for cFos,
cJun, calpain I, and cleaved caspase 3 at 20 min, 2 h, or
24 h after stimulation. Despite a trend toward an early
increase in cFos and cJun (Fig. 3A), and a later increase in
calpain I and caspase 3 (Fig. 3B), ANCOVA (with beta-
actin as covariate) revealed no significant effect of stim-
ulation on any of these biomarkers (F(1,65)  0.53
f, p 
0.05). These findings confirm that the synaptic effects
observed in synaptoneurosomes were not likely from a
small sample of cells that had survived a stimulation-
induced cell death event. These findings also raise the
possibility that the maladaptive effects of nociceptive in-
put may be reversible.
Nociceptive stimulation below SCI increases
synaptic GluA1 and decreases synaptic GluA2 in the
ventral horn neuropil in a time-dependent manner
The observed synaptoneuromal changes in GluA1/GluA2
suggest a broad shift in total synaptic content toward a
GluA2-lacking AMPAR profile; however, biochemical
methods do not provide resolution at a single-cell level to
assess whether these changes occur within a uniform
population of cells to impact excitability. To test for
GluA1/GluA2 ratio shifts in a well-phenotyped neuronal
population of clinical significance, we targeted large mo-
tor neurons in the ventral horn. This was accomplished
using a blinded, randomized analytical workflow of auto-
mated robotic high-resolution spinning disk confocal mi-
croscopy, followed by 3D blind iterative deconvolution,
and automated image analysis to explicitly quantify syn-
aptic and extrasynaptic AMPAR puncta on large ventral
horn neurons and surrounding dendritic fields (Fig. 1).
Large-scale analysis of 90,000 confocal images of
large ventral motor neurons revealed a significant time-
dependent increase in GluA1 puncta colocalized to
synaptophysin-labeled synapses in INS-treated subjects
relative to unstimulated controls (Fig. 4A,B). ANOVA con-
firmed main effects of stimulation and time for synaptic
GluA1 (F(1,536) 30.20
g, p 0.01 and a significant Time
Stimulation effect for synaptic GluA2 (F(1,493)  18.62
h; p
 0.01). Pairwise comparisons revealed that INS signif-
icantly increased synaptic GluA1 by 20 min poststimulation
(p  0.05), whereas GluA2 levels remained unchanged (Fig.
4E, p  0.05). At 2 h poststimulation, synaptic GluA1 ex-
pression remained elevated, whereas synaptic GluA2 was
significantly diminished (Fig. 4F; p  0.05). The decrease in
GluA2 between 20 min and 2 h after nociceptive stimulation
suggests turnover of AMPAR subtypes from a calcium-
impermeable GluA2-containing population to calcium-
permeable GluA2-lacking AMPARs.
Nociceptive stimulation decreases GluA2 expression
first at extrasynaptic sites, then at synaptic sites on
ventral horn neurons in vivo
Cell culture work has demonstrated activity-dependent
AMPARs trafficking occurs in distinct phases. First,
AMPARs are trafficked from intracellular endosomes
into extrasynaptic plasma membrane. They are then
moved laterally into the synapse by means of a distinct
molecular mechanism (Borgdorff and Choquet, 2002;
Park et al. 2004). We sought to determine whether in
vivo INS engages distinct time-dependent changes in
extrasynaptic and synaptic distribution of GluA1 and
GluA2 in the injured spinal cord. Using custom de-
signed automated image analysis macros, we narrowed
the focus of analysis to the plasma membrane compart-
ment of lumbar ventral spinal motor neurons to assess
the localization of GluA1 or GluA2 at extrasynaptic and
synaptic sites (Fig. 5A–L). Automated analysis of a single
optical plane (algorithmically-selected) from 2400 motor
neurons revealed changes in GluA1 that were tightly cou-
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pled between extrasynaptic and synaptic sites, whereas
GluA2 showed distinct temporal features at extrasynaptic
and synaptic sites, resulting in a net increase in GluA1–
GluA2 ratio (Fig. 5A–L), but through distinct mechanisms
at different time points. At extrasynaptic sites, GluA1
rapidly increased and GluA2 decreased by 20 min post-
INS (Fig. 5M). However, at synaptic sites only GluA1
increases were seen, with no change in GluA2 (Fig. 5N).
Figure 3. Assessment of neuronal activity and cell death markers following nociceptive stimulation. Linear Western blot quantification
of cell activity and death in cytosolic fractions of ventral lumbar spinal cord, assessed at (A) 20 m, (B) 2 h, or (C) 24 h after intermittent
nociceptive stimulation. ANOVA showed no significant increase in broad neuronal activity marker cFos, in other more specific markers
of apoptotic cell death (cJun, cleaved caspase3) or in calcium-mediated cell death (calpain I). No significant differences were
observed for beta-actin loading control (p  0.05). Bars represent mean for n  4 subjects/factorial group (n 12 for INS main effect;
n  8 for time main effect; n  4 for interaction) with three independent Western blot runs per subject. Error bars represent standard
error of the mean.
New Research 9 of 16
September/October 2015, 2(5) e0091-15.2015 eNeuro.sfn.org
By 2 h poststimulation persistent GluA2 removal was
observed at both extrasynaptic and synaptic sites,
whereas GluA1 changes returned to control levels (Fig.
5O,P). An ANOVA confirmed a significant Time  Stimu-
lation interaction on GluA1 expression at extrasynaptic
sites (F(1,535)  8.94
i, p  0.01) and main effects of time
and stimulation at synaptic sites (F(1,534)  7.88
j; p 
0.01). Pairwise comparisons revealed that stimulation sig-
nificantly increased extrasynaptic and synaptic GluA1 at
20 min (p  0.05), and that these effects waned by 2 h (p
 0.05). Analysis of GluA2 revealed significant main ef-
fects of time and condition at extrasynaptic sites (F(1,493)
 15.16k, p  0.01), and a significant Time  Stimulation
interaction on synaptic GluA2 (F(1,493)  17.93
l, p  0.01).
Pairwise comparisons revealed that INS significantly de-
creased extrasynaptic GluA2 20 min after stimulation (Fig.
6M; p  0.01), followed by a similar decrease in both
extrasynaptic and synaptic GluA2 expression by 2 h after
stimulation (Fig. 5O,P; p  0.01). These findings suggest
that INS-induced maladaptive plasticity in the injured spi-
nal cord may reflect an increased membrane expression
of GluA2 lacking-AMPARs that is initiated extrasynapti-
cally, and then expressed at synaptic sites by 2 h following
stimulation. This has potential implications for timing of ther-
apeutic interventions to reducemotor neuron hyperexcitabil-
ity after SCI.
Specific CP-AMPAR antagonist restores spinal
motor training capacity in the face of nociceptive
stimulation below a complete SCI
To assess behavioral consequences and therapeutic tar-
geting of CP-AMPAR activity in INS-induced spinal plas-
ticity we harnessed a behavioral assay of adaptive
sensorimotor modification in the spinal cord (Grau et al.,
1998, 2006). INS is known to impair spinal cord sensori-
motor training and recovery of locomotor function after
SCI (Crown et al., 2002a; Grau et al., 2004). To test
whether CP-AMPAR over-activity mediates the INS-
induced deficits in motor function, we intrathecally deliv-
ered a specific CP-AMPAR antagonist (Naspm) following
INS and then tested spinal cord sensorimotor training
capacity using a spinal instrumental (response-outcome)
learning task. The spinal training assay requires rats with
complete T2 spinal cord transection to increase the du-
ration of hind-limb flexion (ie, the response) to reduce
exposure to nociceptive electric shock (outcome; Fig. 6A).
Given that the lumbar spinal cord is surgically isolated
Figure 4. Synaptic GluA1 and GluA2 expression in 3-D synaptic
field surrounding ventral horn neurons after intermittent nocice-
ptive stimulation below complete spinal cord injury. Large ventral
horn neurons in the L4–L5 region were assessed for colocaliza-
tion of GluA1/2 (green) to synaptophysin-positive synapses (red)
in nociceptive-stimulated and unstimulated spinally transected
animals. A–D, Representative 3-D confocal images of ventral
horn neurons 2 h after stimulation or control demonstrating an
increase in GluA1 expression (A, B, green), and decreased GluA2
Figure 4. continued
expression (C, D, green) after stimulation. Scale bar, 30 m. E,
Quantification of GluA1 and GluA2 through confocal stacks at 20
min poststimulation shows a significant increase in synaptic
GluA1 (p  0.05) and no change in GluA2. F, Quantification of
GluA1 and GluA2 through confocal stacks at 2 h poststimulation
shows a significant increase in synaptic GluA1 and a concomi-
tant decrease in synaptic GluA2 (p  0.05). Bars represent
mean colocalization through confocal z-series of ventral horn
neurons (124–146 cells per group assessed for GluA1, 105–154
cells per group assessed for GluA2; n  4 subjects/per group; N
 16 rats total). Error bars represent standard error of the mean.
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Figure 5. Ext	n of GluA1 and GluA2 on plasmamembrane of ventral horn neurons after intermittent nociceptive stimulation below complete
spinal cord injury. Large L4–L5 ventral horn neurons in were assessed for colocalization (yellow) of GluA1/2 (green) to synaptophysin-
positive synapses (red) after nociceptive stimulation. Algorithmically selected single confocal planes of peak GluA1/synaptophysin
colocalization for unstimulated (A) and stimulated groups (B), and GluA2/synaptophysin colocalization for unstimulated controls (C) and
stimulated groups (D). E–H, A 2-m-wide cutout of the confocal image containing somatic plasma membrane. I–L, Boxed plasma
membrane fractions enlarged to illustrate representative differences in extrasynaptic (green) and synaptic (yellow) GluA1/2 puncta on motor
neuron plasma membranes. M–P, Quantification of extrasynaptic GluA1/2 puncta and synaptic colocalization of subunit puncta with
synaptophysin. M, Extrasynaptic GluA1 was significantly increased 20 min after stimulation, whereas extrasynaptic GluA2 is significantly
decreased (ANOVA, p  0.05). N, Synaptic colocalization of GluA1 and synaptophysin was also significantly increased (p  0.05),
whereas synaptic GluA2/synaptophysin colocalization is unaltered by stimulation. O, Two hours after stimulation, extrasynaptic GluA1
expression is unchanged between stimulated and unstimulated groups, while extrasynaptic GluA2 remains significantly decreased in
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from the brain, this sensorimotor training occurs in the
spinal circuitry itself providing an assay of endogenous
spinal cord plasticity (Buerger and Fennessy, 1970; Grau
et al., 1998).
Our findings indicate that INS induces an acute modi-
fication of AMPAR function, producing an increase in
Ca permeability that we predict disrupts spinal senso-
rimotor learning. To explore this possibility, we assessed
the impact of blocking CP-AMPARs using Naspm. NS
administration impaired spinal learning in vehicle-treated
subjects (Fig. 6B). Intrathecal delivery of Naspm immedi-
ately following INS produced a significant restoration of
response duration over time (ANOVA, F(1,29)  1.64
m, p 
0.05; Fig. 6C). This finding suggests that INS acutely
undermines adaptive spinal plasticity through CP-AMPAR
activity, and suggests that suppression of CP-AMPAR
overdrive in the injured spinal cord may restore adaptive
spinal synaptic modifications. Naspm has also been
shown to be therapeutically effective when given 24 h
after INS (Huie et al., 2012a).
Discussion
Our results demonstrate that peripheral nociceptive input
below an acute complete SCI induces a form of AMPA-
mediated maladaptive synaptic plasticity that impairs fu-
ture spinal cord training. Nociceptive stimulation directed
GluA1 into ventral horn synaptoneurosomes and en-
hanced its PKC/CamKII site phosphorylation (p-S831).
Confocal imaging revealed time-dependent increases in
GluA1 and decreased GluA2 on large spinal motor neu-
rons, with GluA2 removal occurring first at extrasynaptic
sites followed by synaptic removal 2 h later. These find-
ings suggest that nociceptive stimulation persistently in-
creases trafficking of GluA2-lacking (calcium-permeable)
AMPARs to spinal synapses. The specific CP-AMPAR
antagonist Naspm protected against INS-induced failure
in a spinal sensorimotor learning task, indicating the ne-
cessity of CP-AMPAR activity for maladaptive spinal plas-
ticity. Together, these findings reveal synaptic GluA2-
lacking AMPARs as mechanistic targets for restoring
effective synaptic and behavioral plasticity in the injured
spinal cord in vivo.
continued
response to stimulation (p  0.05). P, Synaptic GluA1/synaptophysin colocalization is unchanged at 2 h poststimulation, but synaptic
GluA2/synaptophysin colocalization is significantly decreased in response to stimulation (p  0.05). Bars represent means for 124–146
cells/group for GluA1, 105–154 cells per group for GluA2; n  4 subjects/per group, N  16 rats total. Error bars represent standard error
of the mean.
Figure 6. Effect of CP-AMPAR antagonist on impaired adaptive sensorimotor performance following intermittent nociceptive
stimulation. A, INS/spinal cord training paradigm. Rats with complete thoracic spinal transection received 6 min of INS to the tail
followed by intrathecal administration of the CP-AMPAR antagonist Naspm (10 mM). Spinal instrumental training task began 20 min
later. B, Vehicle-treated subjects failed to exhibit a progressive increase in response duration over time, indicative of the INS-induced
impairment in spinal adaptation. Naspm increased response duration over time, indicating that blocking CP-AMPAR activity protects
against INS-induced maladaptive spinal plasticity. ANOVA revealed a significant increase in response duration over time in the
Naspm-treated group compared to vehicle-treated animals, n  12 subjects/per group (repeated measures, p  0.05). Error bars
represent standard error of the mean.
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Prior in vitro work has revealed that activity-dependent
CP-AMPAR expression is regulated by rapid receptor
trafficking to synaptic sites in two stages: AMPARs first
insert at extrasynaptic sites and then traffic laterally into
the postsynaptic density (Ehlers, 2000; Bredt and Nicoll,
2003). Our findings indicate that nociceptive stimulation in
vivo engages a similar trafficking cycle for CP-AMPARs in
the injured spinal cord (Fig. 5 M,P). Data from models of
neuronal insult suggest that injury-induced activation of
PKC can mobilize the AMPA-associated protein PICK1 to
the postsynaptic density, where it binds specifically to
GluA2 subunits and promotes the internalization of
GluA2-containing AMPARs (Liu et al., 2006). Thus, GluA2-
lacking CP-AMPAR expression at postsynaptic sites is
amplified though calcium-sensitive PKC activation, and
may be sustained. Our finding that nociceptive stimulation
increases PKC/CaMKII site phosphorylation suggests a
phenotypic switch to sustained CP-AMPAR expression
that is in line with prior observations that PKC inhibitors
can restore adaptive spinal cord plasticity in the face of
nociceptive stimulation (Malmberg et al., 1997; Zeitz et al.,
2001; Ferguson et al., 2008a; Asiedu et al., 2011; King
et al., 2012).
The current study builds on previous findings that
both nociceptive stimuli and spinal cord injury saturate
glutamatergic neurotransmission, undermining adap-
tive spinal motor plasticity (Tillakaratne et al., 2002;
Chau et al., 2002; Ferguson et al., 2012b; Hoy et al.,
2013). Prior work has also shown that both nociception
and SCI generate inflammatory cytokines that amplify
GluA2-lacking AMPAR tone (Ferguson et al., 2008b;
Choi et al., 2010). INS below SCI has recently been
shown to increase expression of the inflammatory cy-
tokine tumor necrosis factor alpha (TNF) leading to
long-term impairment in spinal learning (Huie et al.,
2012a). Prior in vitro studies revealed that TNF drives
AMPAR currents, specifically by increasing synaptic
GluA2-lacking CP-AMPAR expression (Beattie et al.,
2002; Stellwagen et al., 2005; Leonoudakis et al., 2008).
Further, TNF also increases CP-AMPAR expression in
vivo to induce rapid motor neuron death near the site of
SCI (Ferguson et al., 2008b). Inhibiting either TNF or
CP-AMPAR activity (using Naspm) 24 h after INS re-
stores the capacity for adaptive sensorimotor lumbar
learning (Huie et al., 2012a), suggesting that CP-
AMPAR activity not only mediates the acute impact of
nociceptive stimulation but also plays a key role in
sustaining maladaptive plasticity over time. Naspm ef-
ficacy implies that INS does not impair lumbar-sacral
learning simply because of enhanced spinal cord cell
death through over-excitation. We tested this possibil-
ity by assessing a canonical apoptotic cell death
marker (caspase 3), and a marker for calcium-
dependent cell death (calpain I). We complemented
Figure 7. A, Theoretical pathway underlying INS-induced maladaptive plasticity. Following afferent intermittent nociceptive stimula-
tion, increased glutamate release engages postsynaptic AMPA receptors. Calcium influx via CP-AMPARs activates the calcium
detectors PKC and/or CamKI phosphorylating the serine 831 site on GluA1 AMPAR subunit. Serine 831 phosphorylation increases
the open probability of AMPARs, creating a feedforward loop that leads to membrane insertion of extrasynaptic CP-AMPARs. These
receptors are trafficked laterally to the synaptic membrane, further strengthening this excitatory connection. B, Conceptual model of
CP-AMPAR effects on spinal plasticity after SCI. CP-AMPAR activity critically shapes synaptic strength and use-dependent spinal
cord plasticity after injury. Peripheral stimulation below the injury engages CP-AMPAR-mediated calcium influx, activating intracellular
modulators of synaptic plasticity and strengthening excitatory tone to promote adaptive spinal training. However, CP-AMPARs are
hyper-responsive to peripheral input (eg, limb positioning; skin stimulation) and are easily overdriven, resulting in synaptic saturation
that overwhelms the capacity for adaptive spinal cord learning. As CP-AMPAR activity further increased, excitotoxicity and cell death
may occur. Therapeutic intervention to decrease CP-AMPAR over-activity normalizes the balance of synaptic GluA1 and GluA2, and
restores optimal adaptive plasticity.
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these markers with cFos and cJun, two indicators of
acute cell activity that have been shown in cell death
models to be closely associated with both glutamater-
gic excitotoxicity and apoptosis (Anderson et al., 1995;
Hermann et al., 2001; Xu et al., 2005). Western blot
analysis in the present paper showed that INS did not
significantly increase expression of cFos, cJun, calpain
I, or caspase 3. The lack of biochemical evidence for
INS inducing cell death distal to injury indicates that
INS drives a therapeutically reversible form of maladap-
tive spinal cord plasticity in the lumbar circuitry con-
trolling movement. In contrast, work focusing on the
lesion penumbra has found that INS enhances devel-
opment of ongoing apoptosis and cell loss (Grau et al.,
2004; Garraway et al., 2014). Although the impact of
CP-AMPARs in this effect remains unclear, it is possible
that Naspm could reduce excitotoxic components of
secondary injury in addition to its impact on lumbar
sensorimotor training, yielding dual therapeutic effects.
Based on theoretical and experimental evidence, we
suggest a working model that INS alone first engages
GluA2-lacking AMPARs resulting in calcium influx and
activation of calcium detectors PKC and CamKII (Roche
et al. 1996; Barria et al., 1997; Gómez-Pinilla et al., 2007;
Ferguson et al., 2008a; Fig. 7A), which phosphorylate
S831 to further strengthen synaptic GluA1 drive, but not
GluA2 (Fig. 2). For vehicle-treated subjects, the training
session following INS exposure further strengthens this
maladaptive plasticity. In contrast, Naspm treatment re-
sets the metaplastic state of the spinal cord, giving sub-
jects the opportunity to exhibit an adaptive spinal learning
response, initiating a second wave of AMPAR-mediated
plasticity that involves a greater number of GluA2-
containing AMPARs. The data suggest that INS followed
by a combined therapeutic effect of Naspm and spinal
cord training, re-engages the PKC pathway, as evidenced
by additional increases in both pS831 and GluA1 expres-
sion. Together, the data suggest that Naspm and adaptive
training produce an optimal balance of AMPAR drive for
spinal cord learning (Fig. 7B).
This model is consistent with the idea that both CP-
AMPAR over-activity and underactivity may be problem-
atic. Naspm treatment in cultured hippocampal neurons
may block the normal rebound of synaptic strength fol-
lowing tetrodotoxin administration, indicating that CP-
AMPARs are necessary for homeostatic plasticity in the
brain (Hou et al., 2011). CP-AMPAR activity may produce
a continuum of synaptic and behavioral effects, wherein
moderate AMPAR-mediated calcium influx can be bene-
ficial and necessary for adaptive plasticity (as in the sta-
bilization of LTP in the brain, and in performance on the
adaptive spinal sensorimotor task), but as CP-AMPAR
activity increases in response to insult or nociceptive
input, an excitatory saturation level is reached at which
point spinal neurons lose the capacity to encode subtle
simulation patterns, as in the adaptive spinal training task
(Fig. 7B). Therapeutic interventions to restore homeostatic
balance following injury or insult will likely be key in pro-
moting the optimal glutamatergic regulation of adaptive
plasticity. A growing body of evidence has shown that
AMPAR antagonists including Naspm restore neural func-
tion and suppress excitotoxic cell death in models of
epilepsy, ischemia, neuropathic pain, opioid-induced hy-
persensitivity, and motor neuron diseases (Sorkin et al.,
1999, 2001; Van Damme et al., 2003; Walters et al., 2005;
Leonoudakis et al., 2008; Spaethling et al., 2008; Yin
et al., 2012; Cabanero et al., 2013; Dias et al., 2013).
The current study contributes to these findings by pre-
senting a possible cellular mechanism by which peripheral
nociceptive input drives maladaptive spinal cord plastic-
ity. The high incidence of polytrauma associated with SCI
in the human population (Saboe et al., 1991; Sehkon and
Fehlings, 2001; Wang et al., 2001; Hasler et al., 2011)
highlights the need to understand the impact of nocicep-
tive input in the injured spinal cord. Beyond clearly-
defined peripheral injuries, growing evidence suggests
that the injured spinal cord may also be sensitive to
aberrant peripheral input, including limb immobilization
and stretching (Caudle et al., 2011, 2015). Recent work in
SCI patients demonstrates that c-fiber activation impacts
retention of motor learning tasks (Bouffard et al., 2014).
The present results provide a mechanism for these clinical
findings, suggesting that CP-AMPARs represent a thera-
peutic target. The data presented in this study provide
insight into maladaptive spinal plasticity in an isolated
spinal system at acute time points following a complete
SCI. Future work on CP-AMPARs in other SCI models and
at chronic time points will be invaluable for testing the
therapeutic potential of targeted CP-AMPAR antagonism
for mitigating maladaptive plasticity to promote functional
recovery after spinal cord injury.
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